Rudolf H Andreatta

Title: Rudolf H Andreatta: Innovator in Monoclonal Antibodies

Introduction

Rudolf H Andreatta is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical treatments, especially concerning high blood pressure and cardiac insufficiency.

Latest Patents

Rudolf H Andreatta holds a patent for "Novel monoclonal antibodies to human renin and hybridoma cells." This invention relates to monoclonal antibodies that exhibit a high affinity for human renin. The patent also covers the derivatives of these antibodies, the processes for their preparation, and the hybridoma cell lines that produce them. The applications of these antibodies include the qualitative and quantitative determination of human renin, purification processes, and potential treatments for hypertension and cardiac issues. He has 1 patent to his name.

Career Highlights

Andreatta has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical and chemical industries. His work at the company has allowed him to focus on innovative solutions in the field of health and medicine.

Collaborations

Throughout his career, Rudolf H Andreatta has collaborated with notable colleagues, including Christoph Heusser and Sefik Alkan. These collaborations have contributed to the advancement of research and development in monoclonal antibodies.

Conclusion

Rudolf H Andreatta's contributions to the field of monoclonal antibodies have paved the way for advancements in medical treatments. His innovative work continues to impact the healthcare industry positively.